Oncotarget How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more September 27, 2022
Oncotarget Protein-Based Risk Model Predicts Esophageal Cancer Recurrence Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more September 23, 2022
Oncotarget Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more September 1, 2022
Oncotarget Epigenetics and Immunotherapy Combined Fights Rare Lymphoma In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more August 24, 2022
Oncotarget Does a Mechanism Linking Cellular Aging to Cellular Quiescence Exist? Researchers found that diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence... read more August 5, 2022
Oncotarget How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as... read more July 15, 2022
Oncotarget New Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or... read more May 26, 2022
Oncotarget Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma For the first time, researchers revealed the protein interactome, phospho-proteome and total proteome for the... read more May 12, 2022
Oncotarget Gene Variants Investigated in Polish Bladder and Kidney Cancer Two gene variants were studied in large-scale cohorts for their potential roles in bladder and... read more April 27, 2022
Oncotarget Trending With Impact: Analysis of Mutational Burden in NSCLC Researchers conducted a multi-site cohort study of tumor mutational burden among hundreds of patients diagnosed... read more April 21, 2022